Mark W Hahn Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark W Hahn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark W Hahn. Mark W Hahn is a CFO, VP of Finance and Admin in GIGABEAM CORP ($GGBM) and a EVP and CFO in CEMPRA, INC. ($CEMP) and a Chief Financial Officer in Verona Pharma plc ($VRNA) and a Chief Financial Officer in Dova Pharmaceuticals, Inc. ($DOVA).

Address: 4021 STIRRUP CREEK DRIVE SUITE 400 DURHAM 27703 NC

Companies in which Mark W Hahn is an Insider

Dova Pharmaceuticals Inc.

Trading Symbol: DOVA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark W Hahn: Chief Financial Officer
Holdings: 11,344 shares
Latest Transaction: Jan 08 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GIGABEAM CORP

Trading Symbol: GGBM
Industry: RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
Position of Mark W Hahn: CFO, VP of Finance and Admin
Holdings: 0 shares
Latest Transaction: Feb 04 2008

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

MELINTA THERAPEUTICS, INC. /NEW/

Trading Symbol: MLNT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark W Hahn: EVP and CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 27 2017
$MLNT Market Capitalization: $151.90M
$MLNT Previous Close: $3.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Verona Pharma plc

Trading Symbol: VRNA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark W Hahn: Chief Financial Officer
Holdings: 19,054,504 shares
Latest Transaction: Mar 03 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Mark W Hahn

Sentiment: All, DOVA, GGBM, MLNT, VRNA

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 03 2021VRNAVerona Pharma plcHahn Mark WChief Financial Off ...SellS1.1426,72830,57119,054,50419.1 M to 19.1 M (-0.14 %)
Feb 01 2021VRNAVerona Pharma plcHahn Mark WChief Financial Off ...GrantA0.00105,824019,081,23219 M to 19.1 M (+0.56 %)
Jan 08 2019DOVADova Pharmaceutica ...Hahn Mark WChief Financial Off ...Option ExerciseA8.82250,0002,205,000250,000
Jan 08 2019DOVADova Pharmaceutica ...Hahn Mark WChief Financial Off ...GrantA0.008,844011,3442.5 K to 11.3 K (+353.76 %)
Dec 21 2018DOVADova Pharmaceutica ...Hahn Mark WChief Financial Off ...BuyP6.282,50015,7002,5000 to 2.5 K
Oct 10 2018DOVADova Pharmaceutica ...Hahn Mark WChief Financial Off ...Option ExerciseA20.4250,0001,021,00050,000
Oct 10 2018DOVADova Pharmaceutica ...Hahn Mark WChief Financial Off ...Option ExerciseA20.4250,0001,021,00050,000

View all Mark W Hahn insider transactions.

What Is a Rule 10b5-1 Plan?

Rule 10b5 is one of the most important acts put forth by the SEC. It prohibits fraud, misrepresentation, and deceit in the sale and purchase of securities on national exchanges. More ...

What Do the Transaction Codes Mean?

Each transaction listed on the Form 4 filing must be marked with a transaction code. Here is a list and description of transaction codes as used and categorized by the SEC. More ...

What Should I Do When Insiders Are Selling Stock?

It's often said that insider selling can be a hint that they know that their stock is about to underperform the market. Even though this is true in some cases, it's also true that insider selling is frequently simply behind financial reasons of the insiders and have no connection with the company's prospects. More ...

Contact us | Follow us on Twitter